What is pleconaril used for?
Pleconaril is an antiviral drug from viral capsid inhibitor class, manufactured by Schering-Plough and intended for the prevention of acute asthma exacerbations and common cold symptoms in asthmatic patients who have had exposure to picornavirus. It acts by inhibiting viral replication.
What is EV71 virus?
Enterovirus 71 (EV71) neurological disease is a rare but serious complication of infection with enterovirus 71, a virus which most commonly causes the mild childhood illness hand, foot and mouth disease. Cases and outbreaks of enterovirus 71 neurological disease are rare.
How is enterovirus 71 transmitted?
How enterovirus 71 is spread. Spread is from person to person through contamination of hands or objects (for example, toys) with infected faeces. The virus is then taken in by the mouth. Spread also occurs by contact with the saliva, nasal mucus or sputum (phlegm) of an infected person.
What stage does pleconaril work?
Pleconaril is a novel, orally bioavailable drug that is finishing its late-stage clinical trials and will soon be available to the public in treating enteroviral infections. Current results show an impressive decrease in symptoms and time to recovery.
What is the mechanism of action of pleconaril?
The mechanism by which pleconaril exerts its antiviral effect involves inhibition of picornavirus capsid protein function. Specifically, pleconaril integrates within a hydrophobic pocket inside the virion, leading to rigidification and compression of the viral capsid (14, 25, 28, 37, 38, 38a, 39, 40, 48, 52).
When was zanamivir invented?
Zanamivir was first made in 1989 by scientists led by Peter Colman and Joseph Varghese at the Australian CSIRO, in collaboration with the Victorian College of Pharmacy, and the Monash University. Zanamivir was the first of the neuraminidase inhibitors.
What is EV71 vaccine?
On December 3rd 2015, the China Food and Drug Administration (CFDA) approved the first inactivated Enterovirus 71 (EV71) whole virus vaccine for preventing severe hand, foot and mouth disease (HFMD).
How do u get Coxsackie?
Coxsackieviruses are very contagious. They can be passed from person to person on unwashed hands and surfaces contaminated by feces. They also can be spread through droplets of fluid sprayed into the air when someone sneezes or coughs.
What is zanamivir used for?
Zanamivir belongs to the family of medicines called antivirals, which are used to treat infections caused by viruses. Zanamivir is used in the treatment of the infection caused by the flu virus (influenza A and influenza B). This medicine may also be used to prevent and treat swine influenza A.
Is Relenza still on the market?
It is currently marketed by GlaxoSmithKline under the trade name Relenza as a powder for oral inhalation.
Who EV71 vaccine?
Enterovirus 71 vaccines To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up.
Is coxsackie serious?
Most coxsackievirus infections aren’t serious. They typically cause only mild signs and symptoms, such as: Fever. Rash.
What are the first signs of coxsackie?
What are the symptoms and when do they start? Symptoms of fever, poor appetite, runny nose and sore throat can appear three to five days after exposure. A blister-like rash on the hands, feet and in the mouth usually develops one to two days after the initial symptoms.